The MMA sent a letter
of support on Feb. 5 to Rep. Liz Olson (DFL-Duluth), the chief House author on legislation (HF 400
) that would assess an increased license fee on all manufacturers and distributors of opioids who sell their products in the state.
Proceeds from the fee would support addiction treatment, prescriber and patient education, and opioid-related costs to county child protective services. The bills face opposition from drug manufacturers and distributors.
“(The bill) ensures that we all continue to focus on the opioid crisis through providing much needed funding,” states the letter signed by MMA President Doug Wood, MD. “It also ensures that all parties who contributed to the crisis are at the table to help solve the crisis.”
HF 400 received a hearing in the HHS policy committee on Jan. 30 and was passed and referred to the Commerce Committee, which heard the bill on Feb. 6.
A similar proposal (SF 751
) authored by Sen. Julie Rosen (R-Vernon Center) was introduced in the Senate on Jan. 31 and is expected be heard soon.